Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

775 recalls, newest first

Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. D-1111-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. D-1110-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. D-1109-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. D-1108-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. D-1107-2023
Class II · Moderate risk

Capsaicin Cream 0.025%

Product mix-up: Cartons labeled Capsaicin Cream 0.025% may contain tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste

Terminated Labeling / mix-up Avkare LLC NDC 50268-195-60 D-1147-2023
Class II · Moderate risk

Sodium Fluoride 1.1%

Cases of Sodium Fluoride 1.1% Prescription Dental Toothpaste may contain cartons labeled as Capsaicin Cream 0.025% but contain correctly labeled tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste

Terminated Labeling / mix-up Avkare LLC NDC 42291-741-51 D-1146-2023
Class II · Moderate risk

DIANEAL Low Calcium

Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.

Terminated Sterility / contamination Baxter Healthcare Corporation NDC 0941-0409-06 D-1140-2023
Class II · Moderate risk

hello wild strawberry fluoride toothpaste

Labeling: Label Mix-Up: Some hello wild strawberry fluoride toothpaste, packaged in cartons labeled as hello wild strawberry fluoride toothpaste were incorrectly filled in tubes labeled as hello fresh watermelon fluoride free toothpaste.

Terminated Labeling / mix-up Colgate Palmolive Company D-1084-2023
Class III · Low risk

Pluvicto 1

Labeling: Incorrect or Missing Lot and/or Exp Date: vials were labeled with the incorrect lot number and expiration date

Terminated Labeling / mix-up Advanced Accelerator Applications USA, Inc. NDC 69488-010-61 D-1085-2023
Class II · Moderate risk

Rasagiline Tablets 0.5mg

Failed dissolution specifications - results obtained were below spec average.

Terminated Dissolution failure Aurobindo Pharma USA Inc. NDC 0378-1270-93 D-1171-2023
Class III · Low risk

0.9% Sodium Chloride Injection USP

Labeling: Not Elsewhere Classified - the description, warnings, storage information and instructions for use are either missing or partially printed.

Terminated Labeling / mix-up B. Braun Medical Inc. NDC 0264-5802-00 D-1083-2023
Class II · Moderate risk

Rufinamide Tablets

cGMP deviations: Batch was released prior to approval.

Terminated cGMP deviation Aurobindo Pharma USA Inc. NDC 59651-617-08 D-1088-2023
Class II · Moderate risk

Rufinamide Tablets

cGMP deviations: Batch was released prior to approval.

Terminated cGMP deviation Aurobindo Pharma USA Inc. NDC 59651-616-08 D-1087-2023

Recalls by year